Dr. Peter J. Kneuertz is a thoracic surgeon at the James Cancer Hospital in Columbus, Ohio, specializing in minimally invasive surgery for the treatment of lung cancer, esophageal cancer, and other thoracic malignancies, including malignant pleural mesothelioma. He is skilled in Video-Assisted Thoracoscopic Surgery (VATS) and robotic surgery, as well as extrapleural pneumonectomy and bronchoscopy.
Dr. Robert E. Merritt is a general thoracic surgeon and professor and director of the Division of Thoracic Surgery at Ohio State University. Also serving as director of inpatient services at The James Cancer Hospital, Dr. Merritt has special expertise in minimally invasive surgery in the treatment of lung cancer and thoracic malignancies, including malignant
Dr. Philip Linden is the Chief of the Division of Thoracic and Esophageal Surgery at University Hospitals and UH Seidman Cancer Center in Cleveland, Ohio, as well as an associate professor of surgery at Case Western Reserve University School of Medicine. His clinical interests are thoracic cancers of all kinds, including lung cancer and malignant
Dr. Afshin Dowlati is a medical oncologist at the University Hospitals Seidman Cancer Center and a researcher at Case Comprehensive Cancer Center. As the Director of the Thoracic Oncology Program, he specializes in both the biological and clinical management of thoracic malignancies, with a particular interest in small cell lung cancer and malignant pleural mesothelioma.
Dr. Melinda Hsu is a thoracic medical oncologist at University Hospitals Seidman Cancer Center and an Assistant Professor of Medicine at Case Western Reserve University. She specializes in the care of patients with lung cancer, as well as other thoracic malignancies including malignant pleural mesothelioma. Dr. Hsu’s primary objective is to optimize the care of
Dr. Debora S. Bruno is a medical oncologist at University Hospitals Seidman Cancer Center in Cleveland, Ohio. She is focused on caring for patients with lung cancer, thymic malignancies, and malignant pleural mesothelioma, with an emphasis on the use of new therapies that improve the time patients have without disease progression. Dr. Bruno says that
Dr. Jared Weiss is the Section Chief of Thoracic and Head/Neck Oncology and a Professor of Medicine at the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center. He specializes in lung cancer, squamous head and neck cancer, and other cancers including malignant pleural mesothelioma with a focus on the use of immunotherapy,
Dr. Chad Pecot is a thoracic medical oncologist at UNC Health and Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in lung cancer and abnormal tumors inside the chest, including malignant pleural mesothelioma. He chose lung cancer as a specialty because of its lethality, and he is grateful that through research, patients
Dr. Carrie Lee is a thoracic oncologist at the University of North Carolina Health in Chapel Hill, a Professor at UNC School of Medicine, and Director of the Thoracic Oncology Program at UNC Lineberger Comprehensive Cancer Center. Her clinical practice focuses on lung cancer and she has broad experience with traditional chemotherapy protocols as well
A just-released study conducted in the Netherlands provides a mixed assessment of the use of nivolumab-ipilimumab immunotherapy in patients with malignant pleural mesothelioma. While researchers found that the real-world efficacy of the combination was comparable to what was reported in a phase 3 study, they also reported that toxicities – particularly among elderly patients –